$43,288 Vol.
Jan 21, 2026
Nipocalimab / Lupus
Yes
Halda Therapeutics / Haida Therapeutics
Yes
Darzalex Faspro
No
Ottava
Yes
Vaccine
No
Procedure
Yes
Europe
Yes
Carvykti
Yes
Rybrevant
Yes
Trufill
No
Administration
Yes
China
Yes
$43,288 Vol.
Nipocalimab / Lupus
$339 Vol.
Yes
Halda Therapeutics / Haida Therapeutics
$4,472 Vol.
Yes
Darzalex Faspro
$266 Vol.
No
Ottava
$7,631 Vol.
Yes
Vaccine
$7,002 Vol.
No
Procedure
$665 Vol.
Yes
Europe
$568 Vol.
Yes
Carvykti
$355 Vol.
Yes
Rybrevant
$2,497 Vol.
Yes
Trufill
$2,551 Vol.
No
Administration
$16,687 Vol.
Yes
China
$254 Vol.
Yes
This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.This market will resolve based on the next earnings announcement of Johnson & Johnson currently scheduled to take place on January 21, 2026 at 8:30 AM EST.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
This market will resolve to "Yes" if the listed term is mentioned by anyone during this event. Otherwise, the market will resolve to "No".
Any usage of the term, regardless of context, will count toward the resolution of this market.
Pluralization/possessive of the term will count toward the resolution of this market; however, other forms will NOT count.
Instances where the term is used in a compound word will count regardless of context (e.g. joyful is not a compound word for "joy," however "killjoy" is a compounding of the words "kill" and "joy").
If this market requires a specified number of mentions of a person’s first or last name, a full-name mention will count as one mention (e.g., if a market is about “Joe / Biden 5+ times,” a mention of “Joe Biden” will count once).
A Q&A event will count toward the resolution of this market.
If this event is definitely cancelled, or otherwise is not aired by March 31, 2026, 11:59 PM ET, this market will resolve to "No".
The resolution source will be audio of the event.
Market Opened: Jan 12, 2026, 12:39 PM ET
Volume
$43,288End Date
Jan 21, 2026Market Opened
Jan 12, 2026, 12:39 PM ETResolver
0x65070BE91...Outcome proposed: Yes
No dispute
Final outcome: Yes




Beware of external links.
Beware of external links.
Frequently Asked Questions